Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
NT-proBNP in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006
Cardiovascular diseases are responsible for increased plasma NT-proBNP level in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Influence of body weight on plasma NT-proBNP in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007
Relationship between NT-proBNP level, echocardiographic parameters and cardiovascular diseases in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008
C-reactive protein (CRP) levels in obstructive sleep apnea (OSA) patients and relation to severity of OSA Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Relations between cystatin C plasma concentration and cardiovascular complications in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Correlations between severity of nocturnal hypoxemia and level of Galectin-3 in obstructive sleep apnea patients Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view Year: 2019
BNP or VEGF levels do not predict disease severity in obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005
Prevalence of nocturia in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 646s Year: 2006
Prevalence of stroke in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007
Increased rates of obstructive sleep apnea (OSA) in COVID-19-patients Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19 Year: 2021
Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004
Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
Elevated c-reactive protein in patients with obstructive sleep apnea hypopnea syndrome (OSAH) Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007
Serum leptin levels in obstructive sleep apnoea patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Prevalence and predictors of arrhythmia in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011
Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017
The prevalence of high bicarbonate level in patients with obstructive sleep apnea and the association between high bicarbonate level and the severity of obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 707s Year: 2005